Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B0S9
Term | Name | Level | Count |
---|---|---|---|
GO:0001522 | pseudouridine synthesis | 6 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 11 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0031119 | tRNA pseudouridine synthesis | 7 | 1 |
GO:1990481 | mRNA pseudouridine synthesis | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0009982 | pseudouridine synthase activity | 4 | 12 |
GO:0016829 | lyase activity | 2 | 7 |
GO:0016853 | isomerase activity | 2 | 12 |
GO:0016866 | intramolecular transferase activity | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0106029 | tRNA pseudouridine synthase activity | 5 | 9 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 9 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 9 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0004730 | pseudouridylate synthase activity | 5 | 1 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
GO:0016836 | hydro-lyase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 5 | 9 | PF00656 | 0.747 |
CLV_NRD_NRD_1 | 355 | 357 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 376 | 378 | PF00675 | 0.548 |
CLV_NRD_NRD_1 | 382 | 384 | PF00675 | 0.555 |
CLV_NRD_NRD_1 | 405 | 407 | PF00675 | 0.429 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.344 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.436 |
CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.375 |
CLV_PCSK_KEX2_1 | 376 | 378 | PF00082 | 0.548 |
CLV_PCSK_KEX2_1 | 382 | 384 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 407 | 409 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 474 | 476 | PF00082 | 0.399 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.383 |
CLV_PCSK_PC1ET2_1 | 362 | 364 | PF00082 | 0.375 |
CLV_PCSK_PC1ET2_1 | 407 | 409 | PF00082 | 0.521 |
CLV_PCSK_PC1ET2_1 | 474 | 476 | PF00082 | 0.399 |
CLV_PCSK_PC7_1 | 372 | 378 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 357 | 361 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 408 | 412 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.360 |
DEG_APCC_DBOX_1 | 407 | 415 | PF00400 | 0.513 |
DEG_SPOP_SBC_1 | 2 | 6 | PF00917 | 0.745 |
DEG_SPOP_SBC_1 | 423 | 427 | PF00917 | 0.575 |
DOC_CKS1_1 | 17 | 22 | PF01111 | 0.433 |
DOC_CYCLIN_RxL_1 | 92 | 103 | PF00134 | 0.346 |
DOC_MAPK_gen_1 | 60 | 66 | PF00069 | 0.287 |
DOC_MAPK_MEF2A_6 | 257 | 264 | PF00069 | 0.258 |
DOC_PP2B_LxvP_1 | 270 | 273 | PF13499 | 0.323 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.450 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 339 | 343 | PF00917 | 0.518 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.499 |
DOC_WW_Pin1_4 | 292 | 297 | PF00397 | 0.288 |
DOC_WW_Pin1_4 | 30 | 35 | PF00397 | 0.665 |
LIG_14-3-3_CanoR_1 | 110 | 118 | PF00244 | 0.336 |
LIG_14-3-3_CanoR_1 | 130 | 139 | PF00244 | 0.345 |
LIG_14-3-3_CanoR_1 | 173 | 181 | PF00244 | 0.284 |
LIG_14-3-3_CanoR_1 | 224 | 230 | PF00244 | 0.349 |
LIG_14-3-3_CanoR_1 | 247 | 252 | PF00244 | 0.302 |
LIG_14-3-3_CanoR_1 | 257 | 261 | PF00244 | 0.206 |
LIG_14-3-3_CanoR_1 | 333 | 340 | PF00244 | 0.402 |
LIG_Actin_WH2_2 | 82 | 100 | PF00022 | 0.402 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.734 |
LIG_BIR_III_2 | 136 | 140 | PF00653 | 0.553 |
LIG_BRCT_BRCA1_1 | 341 | 345 | PF00533 | 0.424 |
LIG_deltaCOP1_diTrp_1 | 385 | 394 | PF00928 | 0.441 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.296 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.172 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.326 |
LIG_FHA_1 | 293 | 299 | PF00498 | 0.318 |
LIG_FHA_1 | 326 | 332 | PF00498 | 0.397 |
LIG_FHA_1 | 349 | 355 | PF00498 | 0.428 |
LIG_FHA_1 | 447 | 453 | PF00498 | 0.382 |
LIG_FHA_2 | 276 | 282 | PF00498 | 0.385 |
LIG_FHA_2 | 388 | 394 | PF00498 | 0.469 |
LIG_FHA_2 | 426 | 432 | PF00498 | 0.724 |
LIG_FHA_2 | 460 | 466 | PF00498 | 0.400 |
LIG_LIR_Apic_2 | 393 | 397 | PF02991 | 0.466 |
LIG_LIR_Gen_1 | 145 | 154 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 171 | 181 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 242 | 251 | PF02991 | 0.261 |
LIG_LIR_Gen_1 | 301 | 311 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 171 | 177 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 180 | 186 | PF02991 | 0.252 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 242 | 246 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 301 | 307 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 342 | 348 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 449 | 454 | PF02991 | 0.320 |
LIG_MYND_1 | 139 | 143 | PF01753 | 0.464 |
LIG_Pex14_1 | 300 | 304 | PF04695 | 0.242 |
LIG_Pex14_2 | 170 | 174 | PF04695 | 0.291 |
LIG_REV1ctd_RIR_1 | 183 | 192 | PF16727 | 0.336 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.242 |
LIG_SH2_PTP2 | 451 | 454 | PF00017 | 0.441 |
LIG_SH2_SRC | 243 | 246 | PF00017 | 0.336 |
LIG_SH2_STAP1 | 463 | 467 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.290 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.258 |
LIG_SH2_STAT5 | 348 | 351 | PF00017 | 0.478 |
LIG_SH2_STAT5 | 413 | 416 | PF00017 | 0.590 |
LIG_SH2_STAT5 | 451 | 454 | PF00017 | 0.381 |
LIG_SH3_3 | 136 | 142 | PF00018 | 0.477 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.592 |
LIG_SH3_3 | 284 | 290 | PF00018 | 0.242 |
LIG_SH3_3 | 442 | 448 | PF00018 | 0.750 |
LIG_SH3_5 | 142 | 146 | PF00018 | 0.350 |
LIG_SUMO_SIM_par_1 | 278 | 284 | PF11976 | 0.381 |
LIG_SUMO_SIM_par_1 | 295 | 301 | PF11976 | 0.197 |
LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.429 |
LIG_TRAF2_1 | 233 | 236 | PF00917 | 0.307 |
LIG_TRAF2_1 | 429 | 432 | PF00917 | 0.599 |
LIG_TRAF2_1 | 462 | 465 | PF00917 | 0.478 |
LIG_TYR_ITIM | 241 | 246 | PF00017 | 0.258 |
LIG_UBA3_1 | 279 | 286 | PF00899 | 0.248 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.622 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.720 |
MOD_CK1_1 | 425 | 431 | PF00069 | 0.626 |
MOD_CK2_1 | 239 | 245 | PF00069 | 0.251 |
MOD_CK2_1 | 275 | 281 | PF00069 | 0.385 |
MOD_CK2_1 | 425 | 431 | PF00069 | 0.737 |
MOD_CK2_1 | 432 | 438 | PF00069 | 0.647 |
MOD_CK2_1 | 459 | 465 | PF00069 | 0.385 |
MOD_Cter_Amidation | 471 | 474 | PF01082 | 0.537 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.602 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.333 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.487 |
MOD_GlcNHglycan | 365 | 368 | PF01048 | 0.605 |
MOD_GlcNHglycan | 442 | 445 | PF01048 | 0.681 |
MOD_GlcNHglycan | 469 | 473 | PF01048 | 0.470 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.309 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.730 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.406 |
MOD_GSK3_1 | 392 | 399 | PF00069 | 0.521 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.578 |
MOD_GSK3_1 | 422 | 429 | PF00069 | 0.627 |
MOD_GSK3_1 | 434 | 441 | PF00069 | 0.650 |
MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.280 |
MOD_N-GLC_2 | 210 | 212 | PF02516 | 0.242 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.726 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.358 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.336 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.110 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.681 |
MOD_NEK2_1 | 424 | 429 | PF00069 | 0.636 |
MOD_PIKK_1 | 339 | 345 | PF00454 | 0.431 |
MOD_PIKK_1 | 432 | 438 | PF00454 | 0.771 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.325 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.290 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.199 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.482 |
MOD_PKA_2 | 332 | 338 | PF00069 | 0.385 |
MOD_PKA_2 | 456 | 462 | PF00069 | 0.389 |
MOD_Plk_1 | 459 | 465 | PF00069 | 0.396 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.458 |
MOD_Plk_2-3 | 239 | 245 | PF00069 | 0.242 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.372 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.290 |
MOD_Plk_4 | 271 | 277 | PF00069 | 0.343 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.499 |
MOD_ProDKin_1 | 292 | 298 | PF00069 | 0.288 |
MOD_ProDKin_1 | 30 | 36 | PF00069 | 0.665 |
MOD_SUMO_rev_2 | 281 | 288 | PF00179 | 0.247 |
MOD_SUMO_rev_2 | 425 | 435 | PF00179 | 0.622 |
MOD_SUMO_rev_2 | 479 | 486 | PF00179 | 0.441 |
TRG_DiLeu_BaEn_1 | 236 | 241 | PF01217 | 0.247 |
TRG_DiLeu_BaEn_1 | 261 | 266 | PF01217 | 0.258 |
TRG_DiLeu_BaEn_4 | 465 | 471 | PF01217 | 0.400 |
TRG_DiLeu_BaLyEn_6 | 450 | 455 | PF01217 | 0.557 |
TRG_DiLeu_BaLyEn_6 | 95 | 100 | PF01217 | 0.323 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.343 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.427 |
TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.250 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.230 |
TRG_ENDOCYTIC_2 | 451 | 454 | PF00928 | 0.381 |
TRG_ER_diArg_1 | 375 | 377 | PF00400 | 0.565 |
TRG_ER_diArg_1 | 381 | 383 | PF00400 | 0.572 |
TRG_ER_diArg_1 | 475 | 478 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 94 | 96 | PF00400 | 0.334 |
TRG_NLS_MonoExtC_3 | 43 | 49 | PF00514 | 0.483 |
TRG_NLS_MonoExtC_3 | 472 | 477 | PF00514 | 0.401 |
TRG_NLS_MonoExtN_4 | 473 | 478 | PF00514 | 0.399 |
TRG_Pf-PMV_PEXEL_1 | 98 | 102 | PF00026 | 0.386 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IA61 | Leptomonas seymouri | 72% | 97% |
A0A0S4JB03 | Bodo saltans | 51% | 100% |
A0A1X0P1U9 | Trypanosomatidae | 58% | 100% |
A0A3S7X3E8 | Leishmania donovani | 93% | 100% |
A0A422P3K1 | Trypanosoma rangeli | 57% | 100% |
A4HIA0 | Leishmania braziliensis | 83% | 100% |
A4I5I4 | Leishmania infantum | 93% | 100% |
C9ZQW8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
Q09524 | Caenorhabditis elegans | 34% | 100% |
Q3SX07 | Bos taurus | 37% | 100% |
Q4Q7E9 | Leishmania major | 91% | 100% |
V5DQN1 | Trypanosoma cruzi | 60% | 95% |